The United States and four other countries discussed the need to finalize plans for the new African Union stabilization and support mission in Somalia, the U.S. Department of State said in a statement ...
The stock's fall snapped a five-day winning streak.
The Israeli military issued evacuation warnings for 20 more towns and villages in southern Lebanon, signaling a potential ...
The US FDA has granted Kite’s Yescarta (axicabtagene ciloleucel) a Regenerative Medicine Advanced Therapy (RMAT) designation ...
The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst ...
On Wednesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.74 which represents a slight increase of $0.80 or 0.95% from the prior close of $83.94. The stock opened at ...
Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...
An LLC model in biotech brings specific advantages, such as streamlined deal-making, IP ownership, and capital reinvestment ...
International AIDS Society, an association of HIV/AIDS professionals, applauded moves by Gilead Sciences, a biopharma company ...
Surprise: Hannah and I switched Slog days. Because I respect tradition, we’ll begin with the weather, which is quite nice ...
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback